Skip to content
Screener

Beta Bionics BBNX Q1 2025 earnings

Reported May 6, 2025 · After market close

Revenue$17.6MMiss by $2.0M
EPS-$0.52Miss by $0.01
Revenue estimate$19.7M
EPS estimate-$0.51

Next report

Oct 27, 2026 (In 3 weeks)
Revenue estimate$34.8M
EPS estimate-$0.53

Financials

Q1 2025

Income statement

See full
Revenue$17.6M+36.4%
Gross profit$9.0M+24.6%
Operating income-$18.6M-97.2%
Net income-$28.7M-130%
EPS (diluted)-$0.93+55.1%

Balance sheet

See full
Cash & equivalents$42.5M+92.3%
Total debt$7.0M—
Total equity$313.8M+246%
Total assets$338.0M—

Cash flow

See full
Operating cash flow-$20.0M-64.5%
CapEx$333.0K-18.0%
Free cash flow-$20.3M-61.8%

Valuation & ratios

Profitability

See full
Gross margin53.9%-0.5pp
Operating margin-78%-27.0pp
Net margin-101.6%-34.3pp
FCF margin-85.1%-28.3pp

Returns & leverage

See full
Debt / equity0×—
Current ratio15.9×—

Segments

By product

See full
I Let$9.6M-7.2%
Single Use Products$4.2M+142%

By geography

See full
Non Us-—

FAQ

When did Beta Bionics report Q1 2025 earnings?
Beta Bionics (BBNX) reported Q1 2025 earnings on May 6, 2025 after market close.
What were Beta Bionics's Q1 2025 revenue and EPS?
Beta Bionics reported revenue of $17.6M and eps of $-0.52 for Q1 2025.
Did Beta Bionics beat estimates in Q1 2025?
Revenue missed the consensus estimate of $19.7M by $2.0M. EPS missed the consensus estimate of $-0.51 by $0.01.
Where can I find Beta Bionics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-002817) and the 10-Q periodic report (0000950170-25-064504) directly on SEC EDGAR. The filing index links above go to sec.gov.